Institutional shares held 129 Million
42.6K calls
29.6K puts
Total value of holdings $1.36B
$448K calls
$311K puts
Market Cap $1.71B
159,899,008 Shares Out.
Institutional ownership 80.96%
# of Institutions 257


Latest Institutional Activity in CERT

Top Purchases

Q2 2025
Wasatch Advisors Inc Shares Held: 13.5M ($145M)
Q2 2025
Deerfield Management Company, L.P. (Series C) Shares Held: 3.93M ($42M)
Q2 2025
Marshall Wace, LLP Shares Held: 1.51M ($16.2M)
Q2 2025
Ameriprise Financial Inc Shares Held: 5.46M ($58.4M)
Q2 2025
Teacher Retirement System Of Texas Shares Held: 5.67M ($60.7M)

Top Sells

Q2 2025
Riverbridge Partners LLC Shares Held: 43.7K ($468K)
Q2 2025
Exodus Point Capital Management, LP Shares Held: 69.9K ($748K)
Q2 2025
Brown Brothers Harriman & CO Shares Held: 2.79M ($29.9M)
Q2 2025
Gotham Asset Management, LLC Shares Held: 326K ($3.49M)
Q2 2025
Royce & Associates LP Shares Held: 43.5K ($466K)

About CERT

Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. Further, company offers software, comprising mechanistic biosimulation platform, empirical PK/PD biosimulation platform, data standardization and compliance software, scientific informatics platform, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions platform, and market access communication platform. The company serves biopharmaceutical companies, and academic and government institutions. It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, Australia, and China. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.


Insider Transactions at CERT

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
371K Shares
From 17 Insiders
Grant, award, or other acquisition 44.1K shares
Exercise of conversion of derivative security 327K shares
Sell / Disposition
108K Shares
From 8 Insiders
Payment of exercise price or tax liability 102K shares
Open market or private sale 5.41K shares

Track Institutional and Insider Activities on CERT

Follow Certara, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CERT shares.

Notify only if

Insider Trading

Get notified when an Certara, Inc. insider buys or sells CERT shares.

Notify only if

News

Receive news related to Certara, Inc.

Track Activities on CERT